Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase IV open-label trial of silodosin for nocturia in benign prostatic hyperplasia
KCT0003797Phase 4Completed
- Sponsor
- JW Pharmaceutical Corporation
- Start
- Jan 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of silodosin in benign prostatic hyperplasia (BPH), sponsored by JW Pharmaceutical Corporation. Started Jan 2014; status: completed.
02
Drugs
silodosin
03
Conditions
benign prostatic hyperplasia (BPH)
Beyond the preview
Go deeper on KCT0003797.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on KCT0003797.